TREACE JOHN T. (Chief Executive Officer) purchased 0.7% of their position (45K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $264.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/11/2024ACC: 0000950170-24-072078
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+45K
Net shares
Net buyer
$264.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+45K
Price / share
$5.88
Trade value
$264.60K
% of position
0.7%
6/11/2024
6.34M→6.39M
Total
Net shares
+45K
Net value
$264.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2024 | P · Purchase | +45K | $5.88 | $264.60K | 0.7% | 6.34M | 6.39M |
| Total | +45K | $264.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned1.84M
Common Stock
IndirectShares owned1.60M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.47M | Indirect |
| Common Stock | 1.84M | Indirect |
| Common Stock | 1.60M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported